- News
- Sciwind Biosciences
Tag:
Sciwind Biosciences
-
Pfizer has signed a licensing agreement with China-based Sciwind Biosciences for its type 2 diabetes treatment ecnoglutide, in a deal that could generate up to $495 million in milestone payments.24 Feb 2026-10:18
-